| Description | GPRC5B Human Pre-designed siRNA Set A contains three designed siRNAs for GPRC5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GPRC5B siRNA-1: 5 nmol (HPLC) GPRC5B siRNA-2: 5 nmol (HPLC) GPRC5B siRNA-3: 5 nmol (HPLC) siRNA Negative GPRC5B Human Pre-designed siRNA Set A contains three designed siRNAs for GPRC5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GPRC5B siRNA-1: 5 nmol (HPLC) GPRC5B siRNA-2: 5 nmol (HPLC) GPRC5B siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | N-Acetylneuraminyl-fucosyllacto-N-neo-tetraose is used as a reference material in the analysis of milk oligosaccharides | Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis... Read More | Purity>95% (SDS-PAGE) Endotoxin level<1.0 EU/µgFunctionInhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells |